Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	At risk
Total, all-cause mortality	Gliclazide MR	6
Total, all-cause mortality	Sitagliptin	6
Total, all-cause mortality	Pioglitazone	6
Total, all-cause mortality	Metformin	11
Total, other adverse events	Gliclazide MR	6
Total, other adverse events	Sitagliptin	6
Total, other adverse events	Pioglitazone	6
Total, other adverse events	Metformin	11
Total, serious adverse events	Gliclazide MR	6
Total, serious adverse events	Sitagliptin	6
Total, serious adverse events	Pioglitazone	6
Total, serious adverse events	Metformin	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00780715/event-totals